Company: PRGO
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0001585364-25-000056
Chunk: 78

Company: PERRIGO Co plc
Filing Date: 2025-05-07
Form: 10-Q
Item: Item 8
Chunk 78
---
137.9 $130.3 Nutrition104.8 90.6 Digestive Health103.0 122.2 Pain and Sleep-Aids76.6 82.6 Healthy Lifestyle70.4 71.3 Oral Care62.0 64.7 Skin Care48.6 49.6 Women's Health15.0 27.2 Vitamins, Minerals, and Supplements ("VMS")1.6 4.2 Other CSCA(1)0.8 1.4 Total CSCA$620.7 $644.1 CSCISkin Care$111.5 $114.7 Upper Respiratory73.5 69.1 Healthy Lifestyle66.6 64.6 Pain and Sleep-Aids53.6 51.4 VMS37.7 44.6 Women's Health32.4 32.0 Oral Care22.5 28.7 Digestive Health9.6 9.5 Other CSCI(1)15.9 23.3 Total CSCI$423.1 $437.9 Total net sales$1,043.9 $1,082.1 (1) Consists primarily of other miscellaneous or otherwise uncategorized product lines, none of which is greater than 10% of the segment net sales. The following table provides information about contract assets from contracts with customers (in millions):Balance Sheet LocationMarch 29, 2025December 31, 2024Short-term contract assetsPrepaid expenses and other current assets$38.2 $43.9 

10

Perrigo Company plc - Item 1Note 2

We generated net sales in the following geographic locations(1) (in millions):Three Months EndedMarch 29, 2025March 30, 2024U.S.$609.3 $632.3 Europe(2)412.3 419.7 All other countries(3)22.3 30.1 Total net sales$1,043.9 $1,082.1 (1) The net sales by geography are derived from the location of the entity that sells to a third party. (2) Includes Ireland net sales of $11.0 million for the three months ended March 29, 2025, and $